MapLight Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system disorders, today announced the ...
MapLight Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system ...
MapLight Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating ...
MapLight Therapeutics Inc. (MPLT) completed its initial public offering of 16,962,500 shares of common stock at $17.00 per share, including the full exercise of underwriters’ op ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback